On September 11, 2024, Silk Road Medical, Inc (NASDAQ:SILK) stock closed at $27.24 per share with a market capitalization of $1.107 billion.

As of July 4, 2024, the average one-year price target for Silk Road Medical is $22.27/share. The forecasts range from a low of $8.08 to a high of $28.88. The average price target represents a ...

Boston Scientific to acquire Silk Road Medical for $27.50 per share in cash SUNNYVALE, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (“Silk Road”) (NASDAQ:SILK), a leading ...

SUNNYVALE, Calif. (AP) — SUNNYVALE, Calif. (AP) — Silk Road Medical Inc. (SILK) on Tuesday reported a loss of $14.1 million in its first quarter. The Sunnyvale, California-based company said ...

Silk Road Medical lost $1.54 a share in FY2022 on $139 million. The current analyst firm consensus sees similar losses in FY2023, even as revenues rise to $172 million.

On December 21, 2023, Silk Road Medical, Inc (NASDAQ:SILK) stock closed at $11.22 per share. One-month return of Silk Road Medical, Inc (NASDAQ:SILK) was 34.37%, and its shares lost 79.56% of ...

Conference Call Silk Road Medical will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET on Wednesday, November 8, 2023, to discuss its third quarter 2023 financial results.

Silk Road Medical, Inc. (NASDAQ: SILK) is a medical device company located in Sunnyvale, California, and Plymouth, Minnesota that is focused on reducing the risk of stroke and its devastating impact.

In recent trading, shares of Silk Road Medical Inc (Symbol: SILK) have crossed above the average analyst 12-month target price of $43.80, changing hands for $45.33/share. When a stock reaches the ...